166 related articles for article (PubMed ID: 3409797)
1. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Finucci G; Battaglia G; Angeli P; Zuin R
Dig Dis Sci; 1988 Sep; 33(9):1103-9. PubMed ID: 3409797
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
4. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs.
Blei AT; Groszmann RJ; Gusberg R; Conn HO
Dig Dis Sci; 1980 Sep; 25(9):688-94. PubMed ID: 7418592
[TBL] [Abstract][Full Text] [Related]
5. [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
Valla D; Lee SS; Moreau R; Hadengue A; Sayegh R; Lebrec D
Gastroenterol Clin Biol; 1985 Dec; 9(12):877-80. PubMed ID: 3830801
[TBL] [Abstract][Full Text] [Related]
6. Effect of terlipressin on blood volume distribution in patients with cirrhosis.
Kiszka-Kanowitz M; Henriksen JH; Hansen EF; Møller S; Bendtsen F
Scand J Gastroenterol; 2004 May; 39(5):486-92. PubMed ID: 15180188
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
8. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
9. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
11. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
Møller S; Brinch K; Henriksen JH; Becker U
J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
[TBL] [Abstract][Full Text] [Related]
12. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
Møller S; Hansen EF; Becker U; Brinch K; Henriksen JH; Bendtsen F
Liver; 2000 Feb; 20(1):51-9. PubMed ID: 10726961
[TBL] [Abstract][Full Text] [Related]
13. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
14. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension.
Rabol A; Juhl E; Schmidt A; Winkler K
Digestion; 1976; 14(3):285-9. PubMed ID: 955334
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
Romero G; Kravetz D; Argonz J; Bildozola M; Suarez A; Terg R
J Hepatol; 2000 Mar; 32(3):419-25. PubMed ID: 10735611
[TBL] [Abstract][Full Text] [Related]
16. The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Padrini R; Finucci GF; Angeli P; Ruol A
Br J Clin Pharmacol; 1988 Sep; 26(3):273-7. PubMed ID: 3179167
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.
Vachiery F; Moreau R; Gadano A; Yang S; Sogni P; Hadengue A; Cailmail S; Soupison T; Lebrec D
Dig Dis Sci; 1996 Sep; 41(9):1722-6. PubMed ID: 8794785
[TBL] [Abstract][Full Text] [Related]
18. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
[TBL] [Abstract][Full Text] [Related]
19. Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension.
Hadengue A; Lee SS; Moreau R; Braillon A; Lebrec D
Hepatology; 1987; 7(4):644-7. PubMed ID: 3610044
[TBL] [Abstract][Full Text] [Related]
20. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
